Interestingly, KO of JAK–STAT genes in wild-type sgNT cells or in sgTP53/RB1-KO cells treated with vehicle did not influence tumor cell survival (Extended Data Fig. 3f,g), suggesting a specific role of JAK–STAT signaling in lineage plasticity-driven AR therapy resistance. The gene discussed is RB1; the disease is neoplasm.